Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.

@article{Karlsen2012EvaluationOH,
  title={Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.},
  author={Mona Aarenstrup Karlsen and Noreen Sandhu and Claus Kim H\ogdall and Ib Jarle Christensen and Lotte Nedergaard and Lene Lundvall and Svend Aage Engelholm and Anette T\onnes Pedersen and Dorthe Hartwell and Magnus Christian Lydolph and Inga Alice Laursen and Estrid V. S. H\ogdall},
  journal={Gynecologic oncology},
  year={2012},
  volume={127 2},
  pages={379-83}
}
OBJECTIVE Diagnostic factors are needed to improve the currently used serum CA125 and risk of malignancy index (RMI) in differentiating ovarian cancer (OC) from other pelvic masses, thereby achieving precise and fast referral to a tertiary center and correct selection for further diagnostics. The aim was to evaluate serum Human Epididymis protein 4 (HE4) and the risk of ovarian malignancy algorithm (ROMA) for these purposes. METHODS Serum from 1218 patients in the prospective ongoing pelvic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 56 extracted citations

Similar Papers

Loading similar papers…